Twist Bioscience Corporation A Company Enabling Customers To Succeed Through Its Offering Of High-Quality Synthetic Dna Using Its Silicon Platform, And Ildong Pharmaceutical, Today Announced An Agreement Under Which Ildong Will License A Suite Of Twist Vhh Antibody Libraries To Use To Discover And Develop Antibodies For Applications In Immuno-Oncology. This Collaboration With Twist Moves Us Closer To Our Vision Of Becoming A Fully Global Healthcare Company While Also Continuing To Drive Novel Therapies In South Korea Through The Expansion Of Our Pipeline,
